• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Nov 23;15(1):10178.
doi: 10.1038/s41467-024-54334-7. Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice

Gagandeep Singh[SUP] #[/SUP][SUP] 1 2 [/SUP], Juan García-Bernalt Diego[SUP] #[/SUP][SUP] 1 2 [/SUP], Prajakta Warang[SUP] 1 2 [/SUP], Seok-Chan Park[SUP] 1 2 [/SUP], Lauren A Chang[SUP] 1 2 3 [/SUP], Moataz Noureddine[SUP] 1 2 3 [/SUP], Gabriel Laghlali[SUP] 1 2 4 [/SUP], Yonina Bykov[SUP] 1 2 3 [/SUP], Matthew Prellberg[SUP] 1 2 3 [/SUP], Vivian Yan[SUP] 1 2 3 [/SUP], Sarabjot Singh[SUP] 5 [/SUP], Lars Pache[SUP] 6 [/SUP], Sara Cuadrado-Castano[SUP] 1 2 7 8 [/SUP], Brett Webb[SUP] 9 [/SUP], Adolfo García-Sastre[SUP] 1 2 10 11 [/SUP], Michael Schotsaert[SUP] 12 13 14 15 [/SUP]



Affiliations
Abstract

Antigenically distinct SARS-CoV-2 variants increase the reinfection risk for vaccinated and previously exposed population due to antibody neutralization escape. COVID-19 severity depends on many variables, including host immune responses, which differ depending on genetic predisposition. To address this, we perform immune profiling of female mice with different genetic backgrounds -transgenic K18-hACE2 and wild-type 129S1- infected with the severe B.1.351, 30 days after exposure to the milder BA.1 or severe H1N1. Prior BA.1 infection protects against B.1.351-induced morbidity in K18-hACE2 but aggravates disease in 129S1. H1N1 protects against B.1.351-induced morbidity only in 129S1. Enhanced severity in B.1.351 re-infected 129S1 is characterized by an increase of IL-10, IL-1β, IL-18 and IFN-γ, while in K18-hACE2 the cytokine profile resembles naïve mice undergoing their first viral infection. Enhanced pathology during 129S1 reinfection cannot be attributed to weaker adaptive immune responses to BA.1. Infection with BA.1 causes long-term differential remodeling and transcriptional changes in the bronchioalveolar CD11c+ compartment. K18-hACE2 CD11c+ cells show a strong antiviral defense expression profile whereas 129S1 CD11c+ cells present a more pro-inflammatory response upon restimulation. In conclusion, BA.1 induces cross-reactive adaptive immune responses in K18-hACE2 and 129S1, but reinfection outcome correlates with differential CD11c+ cells responses in the alveolar space.


 
Back
Top Bottom